Monitoring long-term treatments in multiple sclerosis

被引：0
|
作者：
Massimo Filippi
Maria A. Rocca
机构：
[1] Neuroimaging Research Unit,Division of Neuroscience
[2] Institute of Experimental Neurology,undefined
[3] Scientific Institute and University Hospital San Raffaele,undefined
来源：
Nature Reviews Neurology | 2010年 / 6卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Patients with relapsing–remitting multiple sclerosis have been shown to benefit from disease-modifying treatments over prolonged periods. More focus should now be placed on monitoring the long-term evolution of this disease (making use of tools such as MRI), alongside the patients' response and adherence to such treatments.
引用
收藏
页码：421 / 422
页数：1
相关论文
共 50 条
  • [21] Long-term effects of childbirth in multiple sclerosis
    D'hooghe, M. B.
    Nagels, G.
    MULTIPLE SCLEROSIS, 2006, 12 : S131 - S131
  • [22] Natalizumab in Multiple Sclerosis: Long-Term Management
    Clerico, Marinella
    Artusi, Carlo Alberto
    Di Liberto, Alessandra
    Rolla, Simona
    Bardina, Valentina
    Barbero, Pierangelo
    De Mercanti, Stefania Federica
    Durelli, Luca
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (05)
  • [23] Long-term Survival in Multiple Sclerosis is Improving
    Wergeland, Stig
    Mannseth, Janne
    Atula, Sari
    Forsberg, Lars
    Glaser, Anna
    Joensen, Hanna
    Magyari, Melinda
    Soilu-Hanninen, Merja
    Viitala, Matias
    Hillert, Jan
    Grytten, Nina
    NEUROLOGY, 2023, 100 (17)
  • [24] Progression in multiple sclerosis - a long-term problem
    Bittner, Stefan
    Zipp, Frauke
    CURRENT OPINION IN NEUROLOGY, 2022, 35 (03) : 293 - 298
  • [25] Real-world infection risk in multiple sclerosis patients on long-term immunomodulatory treatments
    Lambert, Clare McGarvey
    Hussain, Taimoor
    Peters, John
    Longbrake, Erin E.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2025, 94
  • [26] Monitoring long-term efficacy of fampridine in gait-impaired patients with multiple sclerosis
    Filli, Linard
    Zorner, Bjorn
    Kapitza, Sandra
    Reuter, Katja
    Lorincz, Lilla
    Weller, David
    Sutter, Tabea
    Killeen, Tim
    Gruber, Philipp
    Petersen, Jens A.
    Weller, Michael
    Linnebank, Michael
    NEUROLOGY, 2017, 88 (09) : 832 - 841
  • [27] New treatments for multiple sclerosis at what long-term risk? (vol 343, pg 898, 2000)
    Cameron, M. H.
    Bourdette, D.
    LANCET NEUROLOGY, 2014, 13 (05): : 446 - 446
  • [28] Vitamin D and Long-Term Memory in Multiple Sclerosis
    Koven, Nancy S.
    Cadden, Margaret H.
    Murali, Sangita
    Ross, Mitchell K.
    COGNITIVE AND BEHAVIORAL NEUROLOGY, 2013, 26 (03) : 155 - 160
  • [29] Multiple sclerosis. Rehabilitation and long-term course
    Beer, S.
    Kesselring, J.
    OPHTHALMOLOGE, 2014, 111 (08): : 715 - 721
  • [30] LONG-TERM TREATMENT OF FATIGUE IN MULTIPLE-SCLEROSIS
    MURRAY, TJ
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1985, 12 (02) : 201 - 201
12345